Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

Sponsored by Penumbra, Inc.

evt | Article | July 2022

Moving the Peripheral Thrombectomy Field Forward With Computer-Aided Aspiration

With Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; D. Chris Metzger, MD; Patrick E. Muck, MD, RVT, FACS; Jonathan Bonilla, MD; Kush Desai, MD, FSIR; Gloria Salazar, MD, FSIR; Nikki Keefe, MD; Martyn Knowles, MD, MBA, FACS; Joseph J. Ricotta, MD, MS, DFSVS, FACS; Jake Forman, MD; Jean Bismuth, MD, FACS; and Alex Powell, MD

Sponsored by Penumbra, Inc.

evt | Article | January 2026

Expert Perspectives: The Modern PE Landscape and Evolving Care With STORM-PE

With Timothy Fernandes, MD, MPH; Robert Lookstein, MD, MHCDL; Rachel P. Rosovsky, MD, MPH; Clay Wiske, MD; and Adam Reichard, MD

evt | Article | May 2012

One Question... What Are the Five Devices Your CLI Practice Can't Live Without?

With Sean P. Lyden, MD, FACS; Jos C. van den Berg, MD, PhD; Lawrence A. Garcia, MD, FACC, FAHA, FSCAI; Robert Lookstein, MD, FSIR, FAHA; Edward Y. Woo, MD; Mahmood Razavi, MD; Malcolm T. Foster III, MD, FACC; and John H. Rundback, MD

Sponsored by The PERT Consortium™

evt | Article | July 2019 Supplement

The Pulmonary Embolism Response Team Movement: Advancing Practice, Science, and Quality of Care for Acute PE

By Christina Fanola, MD, MSc; Michael Rosenberg, MD; Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; and Kenneth Rosenfield, MD, MHCDS

Advertisement

Advertisement

Sponsored by Bayer HealthCare

evt | Article | July 2012

Current Trends in Interventional DVT Management

A roundtable discussion of the challenges faced in treating deep vein thrombosis and the benefits of endovascular therapy.

By Mark J. Garcia, MD, FSIR; Robert Lookstein, MD; Mehdi H. Shishehbor, DO, MPH; and Jeffrey Wang, MD

Sponsored by Penumbra, Inc.

evt | Article | July 2020

Rethinking Thrombus Removal With the Indigo System: Introducing Lightning Intelligent Aspiration

With Frank R. Arko III, MD; Patrick E. Muck, MD, RVT, FACS; Ripal T. Gandhi, MD, FSIR, FSVM; Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; Michael S. Rosenberg, MD, FSIR, FACR; Eric Moldestad, MD; Gianmarco de Donato, MD; Thomas S. Maldonado, MD; and D. Chris Metzger, MD

Sponsored by The PERT Consortium®

evt | Article | July 2021 Supplement

The Promise of The PERT Consortium® PE Registry

A registry to inform physicians about the modern state of pulmonary embolism care, including risk stratification, diagnosis, and treatment.

By Eric A. Secemsky, MD, MSc, RPVI, FACC, FSCAI, FSVM; Jay Giri, MD, MPH; and Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM

Sponsored by The PERT Consortium®

evt | Article | July 2020 Supplement

The PERT Consortium® COVID-19 PE Registry: Introduction and Implementation

A discussion of the goals of the registry and what types of data are being collected and reported.

By Rachel P. Rosovsky, MD, MPH; George A. Davis, PharmD, BCPS; Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; and Kenneth Rosenfield, MD, MHCDS, FACC, MSCAI; on behalf of THE PERT Consortium®

evt | Article | January 2021

Panel Discussion: Core Elements and Key Adjustments Made for Modern PE Teams

A panel discussion on the essential components of a pulmonary embolism response team, who should be involved, and how to handle communication among team members.

With Jay Giri, MD, MPH; Brent Keeling, MD; and Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM

evt | Article | June 2019

Panel Discussion: What Is the Future of Paclitaxel-Coated Balloons in AV Access?

Key investigators discuss the impact of the JAHA mortality and safety meta-analysis and what it means for ongoing studies, follow-up protocols, informed consent, and more.

With Panagiotis M. Kitrou, MD, MSc, PhD, EBIR; Robert Lookstein, MD, MHCDL, FSIR, FAHA, FSVM; and Scott O. Trerotola, MD

evt | News | October 6, 2021

Medtronic’s IN.PACT AV Access Study’s 24-Month Outcomes Presented

October 6, 2021—Robert Lookstein, MD, presented 24-month outcomes from the IN.PACT AV Access study in a late-breaking clinical trial session at VIVA 2021, the annual Vascular InterVentional Advances meeting held October 4-7 in Las Vegas, Nevada.

evt | News | November 5, 2019

Findings Presented From a Subgroup Analysis of Medtronic's In.Pact AV DCB

November 6, 2019—Medtronic announced that findings from a 6-month subgroup analysis from the IN.PACT AV Access trial were presented by Robert Lookstein, MD, in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.

evt | News | June 13, 2020

Economic Analyses Assess Medtronic's In.Pact AV DCB Versus PTA

June 13, 2020—An analysis assessing the economic impact of using the company's In.Pact AV drug-coated balloon (DCB) versus percutaneous transluminal angioplasty (PTA) in the United States healthcare system was presented by Robert Lookstein, MD, at SIR 2020 Virtual, the Society of Interventional Radiology’s 2020 annual scientific meeting held online June 13–14.

Sponsored by The PERT Consortium™

evt | Article | July 2023 Supplement

Update on the PERC™ Initiative and the PERT Database: 1 Year Later

Efforts of Pulmonary Embolism Research Collaborative (PERC™) to develop consensus regarding components of PE clinical care and outcomes.

By Robert A. Lookstein, MD, MHCDL, and Terry R. Bowers, MD

evt | News | October 27, 2025

Penumbra’s CAVT With Anticoagulation Studied in STORM-PE

October 27, 2025—Penumbra, Inc. announced that the results of the STORM-PE randomized controlled trial showed that mechanical thrombectomy using the company’s computer assisted vacuum thrombectomy (CAVT) system with anticoagulation achieved superior reduction in right heart strain compared to anticoagulation therapy alone in patients with acute intermediate–high-risk pulmonary embolism (PE).

evt | Article | April 2024

An Interview With Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM

The Mount Sinai interventional radiologist and SIR President-Elect stresses the importance of subspecialization and multidisciplinary teamwork in IR, considers the potential of AI for comprehensive and inclusive care, and ponders next steps after BEST-CLI and BASIL-2.

evt | News | April 15, 2026

Medtronic’s IN.PACT AV Access Postapproval Study Reports 12-Month Outcomes

April 15, 2026—Medtronic announced that 12-month findings from the IN.PACT AV Access postapproval study of the company’s In.Pact AV drug-coated balloon (DCB) demonstrated the device’s safety and effectiveness in the treatment of arteriovenous (AV) fistula stenoses in patients with end-stage renal disease (ESRD) on dialysis.

Sponsored by Boston Scientific Corporation

evt | Article | May 2019 Supplement

Roundtable Discussion: The Evolution of the CLI Treatment Algorithm

A multidisciplinary panel shares insights on practice patterns, treatment algorithms, and hopes for future solutions for this challenging disease.

With Ralf Langhoff, MD; Robert A. Lookstein, MD; Miguel Montero-Baker, MD; and Jihad A. Mustapha, MD, FACC, FSCAI

evt | News | June 16, 2025

Penumbra’s STORM-PE Pivotal Trial of Lightning Flash CAVT Completes Enrollment

June 16, 2025—Penumbra, Inc. announced the completion of enrollment in the pivotal STORM-PE prospective, multicenter, randomized controlled trial.

evt | News | April 13, 2026

Penumbra’s CAVT Evaluated in 90-Day STORM-PE Data

April 13, 2026—Penumbra, Inc. announced 90-day results of the STORM-PE randomized controlled trial (RCT) that is evaluating computer-assisted vacuum thrombectomy (CAVT) using Penumbra’s Lightning Flash device plus anticoagulation versus anticoagulation alone for the treatment of patients with acute intermediate-high risk pulmonary embolism (PE).


1
2
3
4

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button